Mpox
-
Mpox webpage
- includes clinical resources.
Pursuant of the Disease Control Regulations (Saskatchewan), 'mpox" has been designated by the Chief Medical Health Officer as an emerging communicable disease. All suspected cases must be reported by telephone within 48 hours to the local Medical Health Officer.
Public health authorities and clinicians are advised to be vigilant ant to consider monkeypox in their differential diagnosis of patients presenting with unusual rash, plus other clinical signs consistent with mpox (example - fever, headache, and/or lymphadenopathy).
Standard contact and droplet precautions should be applied in all healthcare settings when a patient presents with fever and rash. In addition, because of the theoretical risk of airborne transmission of mpox virus, airborne precautions should be applied whenever possible. If a patient presenting for care at a hospital or other health care facility is suspected of having mpox, infection control personnel should be notified immediately.
General information
- Mpox Information for Public Health (eHealth)
- Mpox: For Health Care Professionals (Government of Canada)
- Public Health Agency of Canada - Mpox: Symptoms and Management
- Centers for Disease Control and Prevention - Mpox
- NACI Rapid Response: Updated Guidance on the Use of IMVAMUNE® for the Prevention of Mpox
- Mpox in Canada: What Clinicians Need to Know (National Collaborating Centre for Infectious Diseases - University of Manitoba)
- IPAC Mpox Toolkit
Clinical Resources
What individuals need to know (Government of Saskatchewan Resources)
Case and Contact Management
Testing and transporting samples
- Laboratory Medicine Bulletin on Mpox Testing
- Provincial Microbiology Requisition
- NML Requisition for Special Pathogens
- Specimens must be transported as TDG category B under Temporary Certificate TU 0886.
Reporting
- Reporting Suspected Cases of Mpox (Deputy Chief Medical Health Officer)